Literature DB >> 3531726

Bilateral ovarian involvement as the only manifestation of malignant lymphoma.

B Piura, J Bar-David, M Glezerman, H J Zirkin.   

Abstract

A 16-year-old girl presented with a large pelvic mass. At laparotomy, bilateral ovarian tumors were disclosed and bilateral salpingo-oophorectomy was performed. No evidence of extra-ovarian disease was found. Histopathological examination and histochemical immunoperoxidase studies demonstrated the tumors to be malignant lymphoma of the lymphoblastic type. The patient had radiotherapy and systemic chemotherapy and more than 10 years later she is alive with no evidence of recurrent disease. The rarity of ovarian involvement as the initial manifestation of malignant lymphoma is discussed. The question of whether this patient represents a case of a primary ovarian malignant lymphoma or merely represents a case of ovarian initial manifestation of an occult generalized disease cannot be answered.

Entities:  

Mesh:

Year:  1986        PMID: 3531726     DOI: 10.1002/jso.2930330216

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  3 in total

1.  Clinical features and treatment outcomes of 14 cases of primary ovarian non-Hodgkin's lymphoma: a single-center experience.

Authors:  Xiao-Ying Zhao; Xiao-Nan Hong; Jun-Ning Cao; Shiang-Jiin Leaw; Ye Guo; Zi-Ting Li; Jian-Hua Chang
Journal:  Med Oncol       Date:  2010-05-28       Impact factor: 3.064

2.  Peripheral T/natural killer-cell lymphoma involving the female genital tract: a clinicopathologic study of 5 cases.

Authors:  S Nakamura; M Kato; K Ichimura; Y Yatabe; Y Kagami; R Suzuki; H Taji; E Kondo; S Asakura; M Kojima; S Murakami; K Yamao; T Tsuzuki; G K Adachi; A Miwa; T Yoshidai
Journal:  Int J Hematol       Date:  2001-01       Impact factor: 2.490

3.  Primary ovarian lymphoma in an infant: report of a case.

Authors:  A Türken; A O Ciftci; Z Akçören; V Köseoglu; D Akata; M E Senocak
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.